All Stories

  1. Clinical utility and perils of prescription drug monitoring program–based alert systems

    Article • Pain, April 2018, Wolters Kluwer Health

    Juan Hincapie-Castillo

  2. Development and validation of a complexity score to rank hospitalized patients at risk for preventable adverse drug events

    Article • American Journal of Health-System Pharmacy, November 2017, American Society of Health System Pharmacists

    Juan Hincapie-Castillo

  3. Prevalence of Psychotherapy Surrounding Initiation of Psychotropic Polypharmacy in the Medicaid-Insured Population, 1999–2010

    Article • Psychiatric Services, November 2017, American Psychiatric Association

    Juan Hincapie-Castillo

  4. Consistency of psychotropic drug–drug interactions listed in drug monographs

    Article • Journal of the American Pharmacists Association, November 2017, Elsevier

    Juan Hincapie-Castillo

  5. Use of lithium in patients with unipolar depression

    Article • The Lancet Psychiatry, September 2017, Elsevier

    Juan Hincapie-Castillo

  6. Acute kidney injury risk associated with piperacillin/tazobactam compared with cefepime during vancomycin therapy in hospitalised patients: a cohort study stratified by baseline kidney function

    Article • International Journal of Antimicrobial Agents, July 2017, Elsevier

    Juan Hincapie-Castillo

  7. Bariatric Surgery and Risk for Perinatal Complications

    Article • JAMA Surgery, June 2017, American Medical Association (AMA)

    Juan Hincapie-Castillo

  8. Evaluating the effects of diffused lavender in an adult day care center for patients with dementia in an effort to decrease behavioral issues: a pilot study

    Article • Journal of Drug Assessment, January 2017, Taylor & Francis

    Juan Hincapie-Castillo

  9. Ototopical neomycin exposure in children with nonintact tympanic membranes

    Article • The Laryngoscope, September 2012, Wiley

    Juan Hincapie-Castillo